Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

NICE set to reject Lilly’s Alimta for new use in lung cancer

Drug deemed not cost-effective use of NHS resources in new indication

- PMLiVE

Bayer raises sales predictions for new pharma products

Expects Xarelto, Eylea, Stivarga, Xofigo and Adepas to make €7.5bn at peak

- PMLiVE

Gliptins don’t cause pancreatic cancer say FDA and EMA

Regulators back safety of diabetes medicine class

- PMLiVE

Pharma companies back Rare Disease Day

Genzyme, Shire and more hold global campaigns today

- PMLiVE

Back to school: client service 101

Simple advice to renew your business model for client service

Bayer symbol

Bayer buys Chinese consumer care company

Acquires Dihon Pharmaceutical as Algeta takeover closes

Novartis day

Novartis commits to greater transparency on trials

Will provide anonymised patient-level data but only for new studies

mHealth could be ‘the future’ of healthcare

EC says Europe is preparing for the mHealth revolution

- PMLiVE

NICE relents and gives Pixuvri limited backing

Recommends Cell Therapeutics drug for an aggressive form of cancer

- PMLiVE

dna names Neil Flash as UK MD

Comms veteran leaves Huntsworth Health

- PMLiVE

Gowrley quits MHP for role at Bupa

Agency head leaves less than one year after taken over from Mike Birtwistle

- PMLiVE

Pharma’s four options for innovation

Only genuinely creative companies will profit from the future

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links